Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 9, 2026Reported purchase · Form 4Rehan Verjee · $20.0KOpen the filing ↗
- Sep 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record40821 flagged findings
Reported transactions (Form 4)80since May 29, 2024 · and 13 other holdings
Corporate events (8-K)12since Oct 3, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-13share offering or dilution eventrecentOpen filing ↗“…12,866,782 13,617,445 Shares available for future issuance under the 2021 Incentive Award Plan 3,938,484 1,528,992 Shares…”
+1 more passage from the same document
- “…common stock reserved for future issuance 25,629,674 23,480,092 ATM Program On May 8, 2025, the Company entered into a sales…”
- 2026-05-13capital return (buybacks/dividends)recentOpen filing ↗“…Income Accumulated Deficit Total Stockholders’ Equity Shares Amount Balance at December 31, 2024 50,749,945 $ 5 $ 593,687 $ 770…”
+1 more passage from the same document
- “…current assets 116 — Total cash, cash equivalents and restricted cash $ 85,955 $ 101,721 Supplemental disclosure of cash flow…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 408)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 21, 26SCHEDULE 13G ↗Passive stake · BVF PARTNERS L P/IL · 6.1% · event on Sep 14, 26
- Sep 17, 26SCHEDULE 13D/A ↗Stake with intent to influence · RA Capital Management, L.P. · 19.9% · event on Sep 15, 26 · amendment
- Sep 17, 26SCHEDULE 13G ↗Passive stake · Paradigm BioCapital Advisors LP · 5.8% · event on Sep 10, 26
- Sep 15, 268-K ↗Current report · Other events
- Sep 15, 26424B5 ↗Securities offering
- Sep 14, 26S-3ASR ↗Securities offering
- Sep 11, 26Form 4 ↗Insider transaction
- Sep 9, 268-K ↗Current report · Other events
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Nextech VI Oncology SCSp · 6.0% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
- Aug 4, 26424B5 ↗Securities offering
- Aug 4, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Results
- Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.0% · event on Jun 30, 26
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 2, 268-K ↗Current report · Shareholder vote results
- Jun 1, 26Form 144 ↗Notice of proposed sale
408 filings on record, the oldest from Jun 25, 21.
Listing the 25 most recent filings of the 408 on record.
48
5 senior executive changes2024 – 2026show all 5hide
- Apr 17, 26A senior executive left or was appointed8-K 5.02 ↗
- Apr 2, 26A senior executive left or was appointed8-K 5.02 ↗
- Dec 1, 25A senior executive left or was appointed8-K 5.02 ↗
- Jan 29, 25A senior executive left or was appointed8-K 5.02 ↗
- Oct 25, 24A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Oct 18, 24Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
- May 7, 24A senior executive left or was appointed8-K 5.02 ↗
- Feb 5, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Mar 1, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 3, 22A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 3, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- RA Capital Management, L.P.19.9%Sep 15, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- FMR LLC14.4%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- JANUS HENDERSON GROUP PLC7.2%Mar 31, 26SCHEDULE 13G/A ↗
- Dapice Joshua J.6.6%Mar 31, 26SCHEDULE 13G/A ↗28 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- BVF PARTNERS L P/IL6.1%Sep 14, 26SCHEDULE 13G ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Nextech VI Oncology SCSp6.0%Jun 30, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
- Paradigm BioCapital Advisors LP5.8%Sep 10, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.5.0%Jun 30, 26SCHEDULE 13G ↗
- Todd Harris4.8%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
- Commodore Capital LP4.2%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Canaan XI L.P.1.4%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jun 26, NEXTECH VI ONCOLOGY SCSP filed notice of intent to sell up to $9.5M. That is about 0.58% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
The 90-day window closed with no sale of theirs on record in Form 4.
- Sep 9, 26Buy$20KRehan Verjee↗
- Mar 25, 26Sell$529KGILLA KAPLAN↗
- Feb 12, 26Sell$67KDaniel BensenChief Discovery Officer↗
- Feb 12, 26Sell$196KDaniel BensenChief Discovery Officer↗
- Jan 12, 26Sell$199KDaniel BensenChief Discovery Officer↗
- Jan 12, 26Sell$30KDaniel BensenChief Discovery Officer↗
- Dec 19, 25Sell$250KROBERT J MORE↗
- Dec 12, 25Sell$181KDaniel BensenChief Discovery Officer↗
- Nov 21, 25Sell$5.0MROBERT J MORE↗
- Nov 19, 25Sell$815KDaniel BensenChief Operating Officer↗
- Nov 18, 25Sell$1.2MDaniel BensenChief Operating Officer↗
- Nov 17, 25Sell$299KDaniel BensenChief Operating Officer↗
There are 14 more transactions in this stretch.
Stock compensation, tax and giftsshow the 14 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 15, 26Compensation$9KAlan FuhrmanChief Financial Officer↗
- Sep 15, 26Compensation$27KYuliya RuebVice President, Finance (PAO)↗
- Sep 15, 26Compensation$8KTodd HarrisPresident and CEO↗
- May 5, 26Compensationamount n/aYuliya RuebVice President, Finance (PAO)↗
- May 5, 26Compensationamount n/aBhavesh AsharChief Operating Officer↗
- May 5, 26Compensationamount n/aTodd HarrisPresident and CEO↗
- May 5, 26Compensationamount n/aAlan FuhrmanChief Financial Officer↗
- May 5, 26Compensationamount n/aDouglas J WarnerChief Medical Officer↗
- Mar 26, 26Compensation$120KGILLA KAPLAN↗
- Mar 26, 26Other$2.0MGILLA KAPLAN↗
- Mar 25, 26Compensation$32KGILLA KAPLAN↗
- Mar 13, 26Compensation$13KTodd HarrisPresident and CEO↗
- Mar 13, 26Compensation$13KAlan FuhrmanChief Financial Officer↗
- Sep 15, 25Compensation$6KAlan FuhrmanChief Financial Officer↗
The full record holds 213 transactions and goes back to Jan 1, 23.
Its sector and its market
Tyra Biosciences, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Tyra Biosciences, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Tyra Biosciences, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 408 documents on file, from Jun 25, 2021 to Sep 21, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.